Prevention and treatment of amyloidogenic disease
Details for Australian Patent Application No. 2008203784 (hide)
International Classifications
Event Publications
28 August 2008 Application Open to Public Inspection
Published as AU-B-2008203784
28 August 2008 Complete Application Filed
9 July 2009 Assignment before Grant
Neuralab Limited The application has been assigned to Elan Pharma International Limited
24 March 2011 Assignment before Grant
Elan Pharma International Limited The application has been assigned to Janssen Alzheimer Immunotherapy
19 January 2012 Application Accepted
Published as AU-B-2008203784
17 May 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008203785-Compositions for aerosolization and inhalation
2008203783-Encapsulation of nanosuspensions in liposomes and microspheres
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser